Vyriad

About Vyriad

Vyriad engineers targeted virus platforms to deliver durable in vivo gene therapies, genome editing, and oncolytic virotherapies. Based in Rochester, Minnesota, the company collaborates with medical institutions and pharmaceutical partners to advance therapeutic development, combining preclinical development, manufacturing, and clinical expertise. Their platforms focus on in vivo gene delivery using engineered viral vectors and envelope glycoproteins to treat cancer and genetic diseases. Vyriad emphasizes partnerships and end-to-end development to tailor viral delivery solutions for each next‑